Allianz Asset Management Gmb H Revolution Medicines, Inc. Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 122,545 shares of RVMD stock, worth $6.09 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
122,545
Previous 103,657
18.22%
Holding current value
$6.09 Million
Previous $3.67 Million
23.0%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RVMD
# of Institutions
334Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$783 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$712 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$666 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$526 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$510 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.36B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...